Barinthus Biotherapeutics financials at a glance
| Year | Year | 2021 | 2022 | 2020 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.27M | $44.70M | $4.82M | $0.80M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 5.26% | -198.46% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | -6.27% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.67 | $0.14 | $-1.91 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
34.88m | 37.3m | 0m | 38.57m | 38.92m |
| OCF | Operating Cash Flow |
|
$-32.58M | $-14.43M | $-11.03M | $-50.93M | $0.00M |
| FCF | Free Cash Flow |
|
$-33.73M | $-20.57M | $-11.32M | $-52.08M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.30 | $-0.55 | $-442.56 | $-1.47 | $0.00 |